About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01257633

Surgical Treatment of Early Stage Glotto-supraglottic Laryngeal Cancer Via Transoral Resection With Robotic Assistance

The main objective of this study is to determine the rate of healthy surgical margins after tumor resection in transoral robot-assisted surgery for glottic and/or supraglottic early stage (T1-T2) lary...

Lead sponsor: Centre Hospitalier Universitaire de Nīmes•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Centre Hospitalier Universitaire de Nīmes

Age

18 - 90 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•The subject has signed consent
•The subject must be a member or beneficiary of a health insurance plan
•The patient is available for 12 months of follow-up
•The subject has a cancer of the larynx:
•classified T1 or T2 in the TNM
•glottic localization and / or supraglottic regardless of node status
•with or without a history of head and neck cancer
•The subject does not have distant metastasis (M0)
•A decision for endoscopic robot-assisted surgery is retained in multidisciplinary meeting

Exclusion Criteria

•\-

Related studies

Not Yet RecruitingPhase 2/3

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

NCT07440290 · Haematological Malignancy, Malignant Neoplasm, and more

Not Yet RecruitingPhase 2

Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC

NCT07400094 · Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, and more

COMPLETEDPhase 1

The Objective is to Respond to Patients' Needs in the Field of Larynx Replacement

NCT00576134 · Swallowing Disorders, Dysphagia, and more

Feasibility Study CORPPS

NCT05406024 · Esophageal Neoplasm, Laryngeal Neoplasms

Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal Carcinoma

NCT04995120 · Laryngeal Cancer, Hypopharynx Cancer, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 17, 2025Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment54

Start dateApr 2011

Last updatedNov 17, 2025

Condition

Laryngeal Neoplasms

Locations shown

CHU de Nîmes - Hôpital Universitaire Carémeau

Nîmes, Gard

CHU de Montpellier - Hôpital Gui de Chauliac

Montpellier

CHRU de Toulouse - Hôpital de Rangueil

Toulouse

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 17, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions